Event-free survival (EFS) with neoadjuvant nivolumab (NIVO) plus platinum- doublet chemotherapy (chemo) versus chemo by surgical outcomes in resectable non-small cell lung cancer (NSCLC) from CheckMate 816
LUNG CANCER（2023）
关键词
cell lung cancer,neoadjuvant nivolumab,lung cancer,chemotherapy,event-free,platinum-doublet,non-small
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要